Skip to content

Evaluating the Efficacy of the Management of an Online Program of Cognitive Behavioral Therapy for Primary Insomnia

Pilot Study Evaluating the Efficacy of the Management of an Online Program of Cognitive Behavioral Therapy for Primary Insomnia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02539862
Acronym
NEXPERTSANTE
Enrollment
46
Registered
2015-09-03
Start date
2015-07-09
Completion date
2016-05-31
Last updated
2018-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Insomnia

Keywords

Insomnia, behavioral and cognitive therapies

Brief summary

The purpose of this study is to evaluate the effectiveness of the management of chronic primary insomnia patients by a computer program guidance of behavioral and cognitive therapies for insomnia (BCT-I).

Detailed description

Chronic insomnia is a common sleep disorder (prevalence = 10%) and a risk identified on the physical and mental health. Currently, the treatment involves the prescription of drug treatments by general practitioners, which may be unsuitable for the medium term. It is better to turn to Behavioral and Cognitive Therapies for Insomnia (BCT-I) in the case of primary chronic insomnia. The objective of this study is to evaluate the effectiveness of a computer program guidance BCT-I in patients with chronic primary insomnia. This biomedical research psychotherapeutic assessment will be randomized, controlled versus psychoeducation and conducted in 46 patients with chronic primary insomnia (defined according to Diagnostic and Statistical Manual-5) for which a supported by BCT-I is indicated. The 46 patients will be randomized into two groups. The subjects in Group 1 will be supported by BCT-I online. And the subjects in group 2 will receive psychoeducation. All patients will be followed by the research team for three months, during which 3 visits (V0 = pre-selection; V1 = visit of randomization and start of the program; V2 = 3 months follow-up visit and end of the study) will be performed in the University Hospital Sleep Disorder Unit of Montpellier. Patients in Group 1 will conduct BCT-I online at home therapy. Patients in group 2 will receive a structured 45-minute session information insomnia (psychoeducation = work performed daily by clinicians in charge of insomnia problems) to the visit 1. All patients in the study will be equipped 2 sensors for the registration of sleep data. The primary endpoint will be based on the severity of insomnia measured by the ISI after the last online psychotherapy session (3 months) between the 2 groups of patients (BCT-I online and without treatment - psychoeducation ). The analyse efficacity to be conducted by intention to treat.

Interventions

OTHERcognitive behavioral therapy online

The cognitive behavioral therapy online program is delivered through an accessible web application on a web browser with a personal password

OTHERpsychoeducation

the psychoeducation is delivered by a doctor

Sponsors

Institut National de la Santé Et de la Recherche Médicale, France
CollaboratorOTHER_GOV
University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* age between 20 and 65 * disorder diagnosis of chronic insomnia (according to Diagnostic and Statistical Manual-5) * sleep efficiency \<80% * Index severe insomnia: ISI\> 14/28 * have a computer at home * Practicing internet regularly in everyday life * have a personal email address

Exclusion criteria

* Clinically suffer from insomnia comorbid linked to other sleep disorders * Presenting an unbalanced psychiatric disorder * Have Score Beck Depression Inventory (BDI-II) \>29 * Have neurological disorders * Have severe medical conditions that can affect the quality of sleep * Have Hypnotic, Anxiolytic, antidepressants Treatment \> 2 * Have antipsychotics, opioids, anticonvulsants, anti-parkinson treatment * Having a disorder of substance use (alcohol, drugs) in the last 6 months * Having undertaken a meridian trance journey (± 3H) in the preceding month or during the study period * Already be treated with CBT-I

Design outcomes

Primary

MeasureTime frameDescription
insomnia severity measured100 daysThe primary endpoint will focus on the severity of insomnia measured by the Index severe insomnia (ISI) at the end of the last session of CBT (3 months) between the 2 groups of patients (CBT-I online and psychoeducation).

Secondary

MeasureTime frameDescription
Sleep latency100 dayscollection of data with actiwatch2 sensor
duration of night wakings100 dayscollection of data with actiwatch2 sensor
total sleep time100 daysThe total sleep time measured by sleep diary and actometer (Actiwatch 2 Sleep).
sleep efficiency100 daysduration of of sleep time compared to the time window passed to bed
quantity of hypnotic treatment100 daysnumber of hypnotic which will be consume by patient
adherence to CBT-I program online100 daysthe number of steps performed in the program, and the weekly frequency of connection.
Sleep quality100 dayssleepiness score assessed by a specific questionnaire

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026